"A reasonable juror could find that the defendants’ 'blaming supply,' making uncompetitively high bids, and falsely citing ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political currents in its efforts to save the deal.

Prescription drug prices can be costly. What are you supposed to do if you can't afford medication? In this episode, Dan ...

Laws focused lowering drug prices have expanded in 15 states, with new boards and payment limits shaping affordability since 2017.

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

Plus, how a little-known Utah lender became First Brands’ biggest creditor and Novo Nordisk gatecrashes Pfizer’s latest deal ...

The Financial Times covers significant financial stories. EQT considers acquiring German marketplace Mobile.de. Delaware's attorney-general warns OpenAI over public interest. Aquarian Holdings ...

Buyout bosses intend to contest any attempt by competition watchdog to disqualify them as directors of British companies ...

Whatever political opposition existed around restricting drug prices through government intervention — and there was quite a ...